Cite
Testing for Verification Bias in Reported Malignancy Risks for Side-Branch Intraductal Papillary Mucinous Neoplasms: A Simulation Modeling Approach
MLA
Davis T. Weaver, et al. Testing for Verification Bias in Reported Malignancy Risks for Side-Branch Intraductal Papillary Mucinous Neoplasms: A Simulation Modeling Approach. Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fb72d6fe1baee341e7060792484f0379&authtype=sso&custid=ns315887.
APA
Davis T. Weaver, Alec J. Megibow, Brian M. Wolpin, Lincoln L. Berland, Anna P. Lietz, Chin Hur, Pari V. Pandharipande, Chung Yin Kong, Sarah F Mercaldo, Amy B. Knudsen, & Mary Linton B. Peters. (2019). Testing for Verification Bias in Reported Malignancy Risks for Side-Branch Intraductal Papillary Mucinous Neoplasms: A Simulation Modeling Approach.
Chicago
Davis T. Weaver, Alec J. Megibow, Brian M. Wolpin, Lincoln L. Berland, Anna P. Lietz, Chin Hur, Pari V. Pandharipande, et al. 2019. “Testing for Verification Bias in Reported Malignancy Risks for Side-Branch Intraductal Papillary Mucinous Neoplasms: A Simulation Modeling Approach,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fb72d6fe1baee341e7060792484f0379&authtype=sso&custid=ns315887.